Puma Biotechnology (PBYI) Invested Capital (2017 - 2026)

Puma Biotechnology's Invested Capital history runs 9 years deep, the most recent figure standing at $11.3 million for Q1 2026.

• Quarterly Invested Capital fell 75.11% year-over-year to $11.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $101.5 million (down 44.01% YoY) and the FY2025 annual result came in at $22.5 million, down 50.31% from the prior year.
• Invested Capital was $11.3 million for Q1 2026 at Puma Biotechnology, down from $22.5 million in the prior quarter.
• Across five years, Invested Capital topped out at $45.3 million in Q1 2024 and bottomed at $11.3 million in Q1 2026.
• A 4-year average of $33.0 million and a median of $34.0 million in 2023 frame the typical range for Invested Capital.
• Annual changes were most pronounced in 2024 — Invested Capital jumped 300.01% — and 2026, when it slumped 75.11%.
• Puma Biotechnology's Invested Capital stood at $34.0 million in 2023, then jumped by 33.33% to $45.3 million in 2024, then slumped by 50.31% to $22.5 million in 2025, then sank by 49.9% to $11.3 million in 2026.
• Business Quant data shows PBYI's Invested Capital at $11.3 million in Q1 2026, $22.5 million in Q4 2025, and $33.7 million in Q3 2025.